1.0 2026-03-31 20:26:49 UTC 2026-08-31 04:42:51 UTC Enviomycine SmallMolecule Enviomycine is a compound with the chemical formula C25H43N13O10. Enviomycine belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. With an average molecular weight of 685.70 g/mol, Enviomycine is a heavy molecule. It is found in or released from one recorded source: healthcare, pharmaceuticals & veterinary products, specifically antibiotics. Recorded exposure routes for this compound include oral and inhalation. (3R,4R)-3,6-Diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4R)-2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl]-6-[(carbamoylamino)methylene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadecau000du000an-15-yl]-4-hydroxyhexanamide (3R,4R)-3,6-Diamino-N-[(3S,6Z,9S,12S,15S)-3-[(4R)-2-amino-3,4,5,6-tetrahydropyrimidin-4-yl]-6-[(carbamoylamino)methylene]-9,12-bis(hydroxymethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-15-yl]-4-hydroxyhexanamide (non-preferred name) (3R,4R)-3,6-Diamino-N-{(3S,6Z,9S,12S,15S)-6-[(carbamoylamino)methylene]-9,12-bis(hydroxymethyl)-3-[(4R)-2-iminohexahydro-4-pyrimidinyl]-2,5,8,11,14-pentaoxo-1,4,7,10,13-pentaazacyclohexadecan-15-yl}-4u000du000a-hydroxyhexanamide (non-preferred name) (R)-1-((3R,4R)-4-Hydroxy-3,6-diaminohexanoic Acid)-6-(L-2-(2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl)glycine)viomycin (R)-1-(threo-4-Hydroxy-L-3,6-diaminohexanoic Acid)-6-[L-2-(2-amino-1,4,5,6-tetrahydro-4-pyrimidinyl)glycine]viomycin Enviomycin Tuberactinomycin N TUM UNII-XU299C23A2 UNII:XU299C23A2 C25H43N13O10 685.325585 (3R,4R)-3,6-diamino-4-hydroxy-N-[(3S,6Z,9S,12S,15S)-2,5,8,11,14-pentahydroxy-6-{[(C-hydroxycarbonimidoyl)amino]methylidene}-9,12-bis(hydroxymethyl)-3-[(4R)-2-imino-1,3-diazinan-4-yl]-1,4,7,10,13-pentaazacyclohexadeca-1,4,7,10,13-pentaen-15-yl]hexanimidic acid (3R,4R)-3,6-diamino-4-hydroxy-N-[(3S,6Z,9S,12S,15S)-2,5,8,11,14-pentahydroxy-6-[(C-hydroxycarbonimidoylamino)methylidene]-9,12-bis(hydroxymethyl)-3-[(4R)-2-imino-1,3-diazinan-4-yl]-1,4,7,10,13-pentaazacyclohexadeca-1,4,7,10,13-pentaen-15-yl]hexanimidic acid 33103-22-9;33987-25-6 C1CNC(=N[C@H]1[C@H]2C(=O)NC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N/C(=C\NC(=O)N)/C(=O)N2)CO)CO)NC(=O)C[C@H]([C@@H](CCN)O)N)N InChI=1S/C25H43N13O10/c26-3-1-16(41)10(27)5-17(42)33-12-6-31-23(47)18(11-2-4-30-24(28)37-11)38-20(44)13(7-32-25(29)48)34-21(45)14(8-39)36-22(46)15(9-40)35-19(12)43/h7,10-12,14-16,18,39-41H,1-6,8-9,26-27H2,(H,31,47)(H,33,42)(H,34,45)(H,35,43)(H,36,46)(H,38,44)(H3,28,30,37)(H3,29,32,48)/b13-7-/t10-,11-,12+,14+,15+,16-,18+/m1/s1 HPWIIERXAFODPP-GHBBWTPBSA-N Organic compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Cyclic peptides 1,2-aminoalcohols 1,3-aminoalcohols Azacyclic compounds Carboximidamides Cyclic carboximidic acids Diazinanes Guanidines Hydrocarbon derivatives Imines Isoureas Monoalkylamines Organopnictogen compounds Polyols Primary alcohols Propargyl-type 1,3-dipolar organic compounds Secondary alcohols 1,2-aminoalcohol 1,3-aminoalcohol 1,3-diazinane Alcohol Aliphatic heteromonocyclic compound Amine Azacycle Carboximidamide Carboximidic acid Carboximidic acid derivative Cyclic alpha peptide Cyclic carboximidic acid Guanidine Hydrocarbon derivative Imine Isourea Organic 1,3-dipolar compound Organic nitrogen compound Organic oxygen compound Organoheterocyclic compound Organonitrogen compound Organooxygen compound Organopnictogen compound Polyol Primary alcohol Primary aliphatic amine Primary amine Propargyl-type 1,3-dipolar organic compound Secondary alcohol Aliphatic heteromonocyclic compounds Detected and Not Quantified logp -7.4 logp -1.42 ALOGPS logs -3.65 ALOGPS solubility 1.55e-01 g/l ALOGPS logp -9.6 ChemAxon pka_strongest_acidic 2.5 ChemAxon pka_strongest_basic 11.74 ChemAxon iupac (3R,4R)-3,6-diamino-4-hydroxy-N-[(3S,6Z,9S,12S,15S)-2,5,8,11,14-pentahydroxy-6-{[(C-hydroxycarbonimidoyl)amino]methylidene}-9,12-bis(hydroxymethyl)-3-[(4R)-2-imino-1,3-diazinan-4-yl]-1,4,7,10,13-pentaazacyclohexadeca-1,4,7,10,13-pentaen-15-yl]hexanimidic acid ChemAxon mono_mass 685.325585 ChemAxon smiles C1CNC(=N[C@H]1[C@H]2C(=O)NC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N/C(=C\NC(=O)N)/C(=O)N2)CO)CO)NC(=O)C[C@H]([C@@H](CCN)O)N)N ChemAxon formula C25H43N13O10 ChemAxon inchi InChI=1S/C25H43N13O10/c26-3-1-16(41)10(27)5-17(42)33-12-6-31-23(47)18(11-2-4-30-24(28)37-11)38-20(44)13(7-32-25(29)48)34-21(45)14(8-39)36-22(46)15(9-40)35-19(12)43/h7,10-12,14-16,18,39-41H,1-6,8-9,26-27H2,(H,31,47)(H,33,42)(H,34,45)(H,35,43)(H,36,46)(H,38,44)(H3,28,30,37)(H3,29,32,48)/b13-7-/t10-,11-,12+,14+,15+,16-,18+/m1/s1 ChemAxon inchikey HPWIIERXAFODPP-GHBBWTPBSA-N ChemAxon polar_surface_area 412.29 ChemAxon refractivity 186.22 ChemAxon polarizability 65.21 ChemAxon rotatable_bond_count 10 ChemAxon acceptor_count 23 ChemAxon donor_count 17 ChemAxon physiological_charge 3 ChemAxon formal_charge 0 ChemAxon #<HealthEffect::ActiveRecord_Associations_CollectionProxy:0x00007f724534eb08> 20055267 16736480